NIST Marine Environmental Specimen Bank (Marine ESB)

Background
The National Institute of Standards and Technology (NIST) has been involved in environmental specimen banking since 1979 through collaborations with various research and monitoring programs. Samples from on-going marine related projects are collected and archived at ultra-cold and cryogenic temperatures (-80 C° and -150° C) in NIST's Marine Environmental Specimen Bank (Marine ESB), Hollings Marine Laboratory (HML), Charleston, SC. These samples include: sediments, mussels, oysters, marine mammal tissues and fluids, bird egg contents and feathers, sea turtle tissues and fluids, coral tissue, coralline algae, and fish tissues.
Marine ESB Facility
The Marine ESB was designed and operates under ISO Certified Class 5, 6 and 7 clean room conditions. Stored samples are brought into the bank facility through an ISO Class 6 anteroom and are stored in liquid nitrogen vapor-phase and ultra-cold electric freezers in the ISO Class 7 Freezer Room, Room D104. These clean air laboratories control the concentration of airborne particles to specified limits and are essential in minimizing contamination of samples during processing. In addition, the Marine ESB is a secure area with key-card access restricted to trained Marine ESB personnel or other trained researchers who are escorted by Marine ESB personnel. Personal protective equipment (PPE) is required at all times when entering and working in the Marine ESB. PPE includes disposable Tyvek coverall (full body), open-faced hood and mask or eyes-only hood, boot covers, safety glasses, and gloves (general laboratory vinyl gloves and/or cryogenic gloves). The work activities and required PPE for the Marine ESB are listed in the Job Hazard Analysis Forms which are approved and signed by all Marine ESB personnel, the NIST Supervisor, and the Area Safety Representative for the HML as well as the NIST Hazard Review System which are approved by the Group Leaders, Division Chief, and Lab Directors, when necessary. Environmental conditions in the laboratory (humidity, temperature, and oxygen levels) and freezer temperatures are monitored 24/7 using a monitoring system (1).
Collections
Northern Gulf of Mexico Cetacean Unusual Mortality Event
NIST has been indirectly involved in the response to the 2010 Deep Water Horizon Gulf of Mexico Oil Spill incident. In support of the National Oceanic and Atmospheric Administration, National Marine Fisheries Service, Office of Protected Resources (NOAA/NMFS/OPR), NIST has become the lead repository for frozen marine mammal (primarily bottlenose dolphin, Tursiops truncatus) samples collected in response to this event. Sources of these samples are: stranding events (including the ongoing Northern Gulf of Mexico Cetacean Unusual Mortality Event), live capture health assessments, and dart biopsy collections conducted throughout the Gulf of Mexico region. Since May 2010, NIST has received thousands of tissue samples (no microbial cultures) that were collected in the field and shipped frozen to the Marine ESB for storage following strict Chain of Custody guidelines. The majority of the frozen samples received have come from strandings as a part of the Northern Gulf of Mexico Cetacean Unusual Mortality Event. These samples were collected and shipped from marine mammal stranding network participants, including the Institute for Marine Mammal Studies (IMMS), Gulf World Marine Park, the Emerald Coast Wildlife Refuge (ECWR), NOAA Southeast Fisheries Science Center, Dauphin Island Sea Lab (DISL), and the Audubon Aquatic Institute.
Samples maintained at the Marine ESB are requested by NMFS/OPR to be sent to various laboratories for testing and analyses, including testing for zoonotic pathogens, such as Brucella and Morbillivirus and analyses for polycyclic aromatic hydrocarbons (PAH's) and biotoxins.
In October 2011, NIST Marine ESB personnel were informed by NMFS/OPR that samples shipped out for testing in July, August, and October of 2011 tested positive for marine Brucella, the causal agent of brucellosis. A total of 33 frozen tissue samples, including lung, spleen, kidney, umbilicus, cerebrospinal fluid, placenta and lung lymph node, were shipped from the Marine ESB to Michael Kinsel at the University of Illinois, Zoological Pathology Program, in Maywood, IL for Brucella testing. Since 2011 more samples have tested positive for marine Brucella. Additional samples maintained at the Marine ESB are currently being requested to be shipped for marine Brucella testing as well as more testing in the future. According to a recent study the prevalence of Brucella and Morbillivirus infections, which were investigated as potential alternative causes for increased dolphin deaths, was low in UME dolphins after the oil spill and was no different compared to reference dolphin populations (2).
National Marine Mammal Tissue Bank
The National Marine Mammal Tissue Bank (NMMTB) consists of two ongoing environmental monitoring projects, the Alaska Marine Mammal Tissue Archival Project (AMMTAP), established in 1987 and the Marine Mammal Health and Stranding Response Program (MMHSRP), established in 1990. These projects provide a large percentage of samples banked at the Marine ESB. The NMMTB was formally established by the Marine Mammal Health and Stranding Response Act (Public Law 102-587) and expanded to become a larger program that resulted in several components; the Marine Mammal Stranding Networks, the NMMTB, and a Monitoring and Quality Assurance Program. The MMHSRP is focused on animal health assessment, real-time contaminant monitoring, specimen banking, response to strandings and mass mortalities, quality assurance/quality control of analytical results, and the management of a nationwide database on the health of marine mammal populations. NIST currently maintains the NMMTB and the Monitoring and Quality Assurance Program. The NMMTB houses liver, kidney, blubber/adipose, muscle, and brain tissues from stranded animals which include cetaceans, pinnipeds, and polar bears (3).
Other Collections
Tissue collections from other projects are obtained from healthy animals or animals that are not suspected to be infectious. These include sea bird egg contents, marine mammal tissues taken from Alaskan subsistence harvested animals, marine mammal tissues taken from incidental takes, marine mammal fluids taken from human managed animals, bivalves, sport fish tissue, sea turtle tissues and fluids, sea turtle egg contents, and specimens from live captured cetaceans. These samples pose little zoonotic risk when handled with required PPE.
Risk Assessment
Known Agent and Strain Brucella
Marine mammal isolates of the genus Brucella (Brucella pinnipedialis and Brucella ceti, sometimes referred to as Brucella maris) are potentially zoonotic, causing the disease Brucellosis. However, the frequency of transmission to humans is unknown. There have been a total of four confirmed human infections of marine Brucella. Three of these infections are naturally occurring thought to have been caused by the consumption of raw fish (4), (5) since none of the patients had any contact with marine mammals. The fourth, a laboratory acquired infection, was mild and presented no complications (6) . Marine mammal isolates of Brucella are not considered select agents by the Centers for Disease Control and Prevention (CDC) and the United States Department of Agriculture/Animal and Plant Health Inspection Service (APHIS) (7).
Brucella is gram negative coccobacilli. Brucella species are thought to be stable in the environment in carcasses and organs up to 135 days, and up to 180 days in blood stored at 4°C. With regards to terrestrial Brucella, laboratory infections typically occur when the bacteria is grown in large cultures. Routes of exposure can include ingestion, direct contact with skin abrasions and mucous membranes, as well as inhalation of the aerosolized agent. Reservoirs of infectious agent include infected tissues, blood, urine, vaginal discharge, and aborted fetuses (8, 9) . Routes of exposure are poorly understood in marine Brucella, with little evidence to support any route of infection. Infectious doses of terrestrial Brucella species are as little as 10 to 100 organisms (10, 11) and the incubation period for terrestrial Brucella can run from 1 to 15 weeks. The infectious dose and incubation period of marine Brucella is not known. Infections can be symptomatic or asymptomatic. When symptoms are present the disease is extremely variable and clinical signs may appear abruptly or insidiously. The disease typically begins with nonspecific flu-like signs such as fever, headache, back pain, malaise and generalized aches. Some patients will recover spontaneously while others develop persistent symptoms that wax and wane. Occasionally additional complications arise including, arthritis, spondylitis, chronic fatigue, anemia, internal abscesses, nephritis, endocarditis and dermatitis.
Neurological signs occur in less than 5 % of patients but can include personality changes, meningitis, uveitis and optic neuritis (9) .
There is no vaccine for brucellosis. Minimizing exposure risk is the best prophylaxis. If an infection does occur, antibiotics like tetracycline can be administered for at least six weeks. The bacteria are typically resistant to penicillin and cephalosporin. Special antibiotics may need to be used in pregnant women; cotrimoxazole has been used with reported success. Since the bacteria do not form spores, they can be easily destroyed using standard disinfectants, (70 % alcohol and 1 % sodium hypochlorite sprays) (8) .
NMFS NOAA has issued Brucella specific biosafety guidelines for stranding network personnel when handling cetaceans or pinnipeds that are suspected of being infected with Brucella. The guidelines name the following animals as being "High-Risk" animals and recommend minimum levels of PPE for necropsies from animals suspected of Brucella infections.
NOAA/NMFS Interim Marine Mammal Brucella specific Biosafety Guidelines for the National Marine Mammal Stranding Network a.) High Risk Animals for Suspect Brucella infections
• Cetaceans: All Species (Pregnant Females, Neonates, Juveniles, SubAdults, Adults with skin or bony lesions)
• Pinnipeds: All Species (Pregnant Females), Harbor Seals (Pups, Yearlings and Sub-Adults) b.) Minimum PPE recommendations for Necropsy (field or laboratory)
• Tyvek suit, gloves, face shields (field necropsies). Additional PPE for procedures that create aerosols, standard PPE plus NIOSH-certified N-95 respirator.
CDC Guidelines for Safe Work Practice in Animal Diagnostic Laboratories a.) PPE for Necropsy Personnel
• Fluid-resistant clothing, gloves (double gloving), cut-resistant glove
• Protection from splashes and aerosols (when risk assessment indicates a high likelihood for zoonotic agents) use transparent face shield (covering eyes mouth and neck) and an NIOSH-certified N-95 respirator.
b.) Disinfection
• Surfaces and floors should be washed with detergent and then disinfected with a 1:10 bleach solution or alcohol.
• Sharp objects placed in puncture resistant containers and washed with detergent solution rinsed and wet with disinfectant or autoclaved.
• Disposable items discarded into a biohazard container for terminal treatment or autoclaving.
• No dirty items or anything used in necropsy removed from room without disinfection and wash hands at end of all activities.
• Waste management of animal tissue -dispose of all necropsy waste using appropriate method as determined by the case-by-case risk analysis assessment.
Brucella Testing Results
Information was obtained from NOAA' ) is worn by all personnel when processing an animal that is known to have been collected from a subsistence harvest. If the origin of the animal is unknown or known to be collected from a stranded cetacean or pinniped standard PPE plus a fitted NIOSH-certified N-95 respirator is worn by all personnel during processing. Cut resistant gloves are also worn on the non-cutting hand of the personnel processing the sample. b.) Samples are thawed on absorbent mats, removed from their bags and rinsed with water to remove any debris or ice crystals. e.) Tissue is transferred to a cutting board covered with Bytac surface protector and a FEP sheet, two -150 gram portions are cut from the whole tissue using a sharpened titanium knife and placed in clean PTFE jars. The jars are sealed and labeled then placed in long-term storage in LN2 vapor-phase (-150 ° C) freezers. c.) Knife handles are unscrewed from the blade taking great care to avoid cuts and all pieces are scrubbed with hot soapy water and rinsed. Cut-resistant gloves and water collection containers are washed thoroughly with hot water. freezer (PTFE disk mill, smasher, spatula, scoop, labeled 15 mL jars, and stainless steel shaker plates) then transferred to a pre-cooled cryocart when needed ( Figure 2 ). All work takes place in a MVE Cryocart unless otherwise stated. c.) After locating the sample, it is removed from an archive LN2 freezer and placed in the cryocart. The sample lid is unscrewed and placed aside. An attempt is made to dislodge the sample from the jar directly into the interior of the smasher with puck removed by hitting the top of the inner ring with the jar overturned. If the sample remains in the jar it will be removed from the cryocart and placed in small FEP bag. The jar and bag will be laid flat on a cutting board covered in Bytac surface protector and an FEP sheet. A sledge hammer wrapped in Bytac and FEP sheeting is used to crack the frozen sample by hammering on the flat side of the jar through the FEP bag. Once the sample is cracked internally or the jar is cracked another attempt to dislodge the sample into the interior of the smasher will typically result in success. d.) When the sample is removed from the jar into the smasher interior and the puck is replaced it is then brought under the compressed air fragmentation device. A 40.9 kg weight is dropped on the smasher from a height of 1 meter fracturing the tissue into smaller pieces. The smasher is placed in the cryocart. The puck and ring are removed and set aside. e.) The lid of the PTFE disk mill is removed, material from the base of the smasher is scraped using the spatula into the disk mill and the lid is replaced. The disk mill is sandwiched between the two stainless steel plates and clamped into the TS-250 shaker. With the lid in place the shaker will vigorously shake the mill for up to 3 minutes pulverizing the contents into frozen powder. Some tissue leakage can occur. f.) To mitigate potential aerosols from leakage that may have occurred milling, it is recommended to wait at least 5 seconds before opening the lid of the TS-250 shaker. This time will allow particles to "settle" before the lid is opened slowly.
g.) The disk mill is placed back in the cryocart. The lid, puck and ring are removed and the resulting tissue in powder form is scooped into jars and capped. Once completed the jars are weighed and weights recorded in the Specimen Bank notebook then jars are stored in an archive LN2 vapor-phase freezer. h.) Immediate cleaning procedures include; wiping down the thawed stainless steel plates with a Tex-wipe and 70 % isopropanol and placing them back in the working freezer for the next homogenization, rinsing the disk mill, smasher, spatula, and scoop with hot water for eventual chemical cleaning (12) . i.) The outside of the cryocart, balance, TS-250 Disk Mill Shaker, and surrounding floor of the working freezer and compressed air fragmentation device is decontaminated with 70 % isopropanol. 
Evaluate and Prioritize Risk
Each task or activity in which specimen bank personnel can come into contact with a potential source of Brucella is evaluated to determine the hazard and the likelihood the hazard will occur. Table 1 outlines the hazard associated with each task by project. Develop or evaluate controls to mitigate exposure Engineering controls and workplace practices provide the primary barrier to injury or exposure while PPE provides secondary protection. Table 2 outlines the engineering and workplace controls in place to mitigate hazards related to potential Brucella exposure for tasks and activities in the Marine ESB. 
Emergency Procedures
In the event of an injury or accident
• Call 9-911 (if needed), treat the injured, and prevent further injury/damages • Collect information on the incident including who, what, when, where, why, and how, and if applicable, gather information from witnesses and others involved in the incident.
• Notify your supervisor or the lab lead (or if unreachable, any supervisor) and the NOAA HML Safety office as soon as possible.
In the event of a spill
• Alert people in the area.
• Cover an area twice the size of the spill with disinfectant soaked-paper towels.
• Wipe down any contaminated stationary equipment or furniture with disinfectant.
• Use forceps, tongs, or broom to remove broken glass and other items; place in sharps container or red bag.
• Remove towels and re-clean area with disinfectant solution.
• Disposable items used are to be put in the biohazard bag for incineration • Reusable clean-up items and other reusable equipment are to be decontaminated using chemical treatment. 
